Keith Dunleavy biography

Dr. Keith R. Dunleavy, M.D., is Chairman of the Board, Chief Executive Officer of the INOVALON HOLDINGS, INC. Dr. Dunleavy has served as our Chief Executive Officer since his organization of our predecessor companies in 1998, as Chairman of the Board since the creation of the Board in 2006, and as President from our foundation until May of 2014. Dr. Dunleavy is responsible for the overall execution of our business plan, strategic relationships, and the identification and realization of our product strategy and vision. During his tenure building Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Dr. Dunleavy received a Bachelor’s degree in Biology modified with Engineering with High Honors from Dartmouth College, where his studies and work focused upon the neurosciences, computer sciences and engineering, and his honors thesis focused on the computer simulation of artificial human cerebellar functional units. He earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, and practiced and was Board Certified in Internal Medicine. Dr. Dunleavy serves as a Director on the Dartmouth Medical School Board of Advisors.

What is the salary of Keith Dunleavy?

As the Chairman of the Board and Chief Executive Officer of Innovator ETFs Trust, the total compensation of Keith Dunleavy at Innovator ETFs Trust is $210,551. There are 10 executives at Innovator ETFs Trust getting paid more, with Peter De Bock having the highest compensation of $2,866,730.